TrialJAMA oncology2019

Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.

Erin D Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.